The Characteristic of Pregnancy in Woman with Rheumatic Mitral Stenosis in Dr. Soetomo Hospital Surabaya from 2015 – 2017
Article Sidebar
Main Article Content
Abstract
Background: Cardiac disease is 1 of the major causes of maternal mortality. Mitral Stenosis (MS) is a particularly high-risk condition for a pregnant woman in emerging countries, the main cause of MS is a complication from rheumatic heart disease. Objective: To study the maternal and perinatal outcome of pregnancies complicated by mitral stenosis from rheumatic heart disease. Methods: We conduct a cross-sectional retrospective study using electronic medical data records in dr. Soetomo General Hospital over the period of 3 years from 2015 – 2017 involving 36 cases of pregnant women complicated by rheumatic mitral stenosis. The maternal and perinatal outcome was reviewed. Result: Most of the pregnant women with rheumatic mitral stenosis were at 29 - 34 weeks of gestational age. Majority of the patient (61,1 %) was in NYHA II classification for heart failure degree. The Degree of MS was moderate (75 %) and severe (25 %), with a maternal mortality rate was 4/36 patients (11,1 %), and all of the patients were with severe MS had class III/IV heart failure. The main reason for hospital admission was heart failure (50 %). 38 % of women with NYHA Class III/IV had severe MS. Most accompanying valve diseases occur at the patient with severe MS, with Tricuspid Regurgitation as the most accompanying valve disease (66,67 %) followed by Mitral Regurgitation (36,11 %) and Aortic Regurgitation (25 %). Percutaneous Transmitral Valve Commissurotomy (PTMC) was the chosen surgical intervention for valve correction. For a patient with Moderate MS, 6/8 (75 %) of the pregnancy terminated at ³ 34 weeks of gestational age, compared with 18/28 (64,28 %) patient with Severe MS the pregnancy terminated at < 34 weeks of gestational age. Cesarean section was the most chosen method of delivery for most of the cases. Fetal weight (4/7 cases) at delivery for Moderate MS was > 2500 g, compared with (7/18 cases) was < 2000 g for Severe MS. APGAR Score for Moderate MS cases was 8-10 for 5/7 cases, compared with Severe MS, 16/24 cases were < 8. Conclusions: Cardiac and obstetric complications from rheumatic mitral disease remain a major challenge in this disease. Early diagnosis and management with good adherent to pre-conceptional and prenatal care remain a key factor for preventing maternal and fetal morbidity and mortality.
Downloads
Article Details
Copyright (c) 2021 Joseph Relmasira, Budi Wicaksono
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Van Hagen I, Thorne SA, Taha N, Youssef G, Elnagar A, Gabriel H, et al. Pregnancy Outcomes in Women with Rheumatic Mitral Valve Disease Results From the Registry of Pregnancy and Cardiac Disease. Circulation. 2018. 137:806–816.
Watkins DA, Cathrine OJ, Colquhoun SM, Karthikeyan G, et al. Global, Regional and National Burden Of Rheumatic Heart Disease, 1990-2015. NEJM. 2017. 377(8):713-722.
Watkins DA, Sebitloane M, Engel ME, Mayosi BM. The Burden Of Antenatal Heart Disease In South Africa: A Systematic Review. BMC Cardiovascular Disorder. 2012. 12:23.
Rothenbühler M, O’Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active Surveillance For Rheumatic Heart Disease In Endemic Regions: A Systematic Review And Meta-Analysis Of Prevalence Among Children And Adolescents. Lancet Global Health. 2014. 2: e717–26.
Stout KK, Otto CM. Pregnancy In Women With Valvular Heart Disease. Heart. 2007. 93:552–558.
Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. Task Force On The Management Of Grown-Up Congenital Heart Disease Of The European Society Of Cardiology (ESC); Association For European Paediatric Cardiology (AEPC); ESC Committee For Practice Guidelines (CPG). ESC Guidelines For The Management Of Grown-Up Congenital Heart Disease (New Version 2010). European Heart Journal. 2010. 31:2915–2957.
Joshi HS, Deshmukh JK, Prajapati JS, Sahoo SS, Vyas PM, Patel IV. Study Of Effectiveness And Safety Of Percutaneous Balloon Mitral Valvulotomy For Treatment Of Pregnant Patients With Severe Mitral Stenosis. Journal of Clinical Diagnosis and Research. 2015;9: OC14–OC17.
Pomini F, Mercogliano D, Cavalletti C, Caruso A, Pomini P. Cardiopulmonary Bypass In Pregnancy. Ann Thorac Surg. 1996. 61:259–268.
Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal. 2011. 32:3147–3197.
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal. 2012. 33:2451–2496.
Soma-Pillay P, Seabe J, Sliwa K. The Importance of Cardiovascular Pathology Contributing To Maternal Death: Confidential Enquiry Into Maternal Deaths In South Africa. Cardiovascular Journal of Africa. 2016. 27:60–65.
Diao M, Kane A, Ndiaye MB, Mbaye A, Bodian M, Dia MM, et al. Pregnancy In Women With Heart Disease In Subsaharan Africa. Archive Cardiovascular Disease. 2011. 104:370–374.
Djusad S, Hakim S, Surya R, Hansens Y, et al. The Outcome of Percutaneous Mitral Balloon Commissurotomy (PMBC) in Pregnant Women with Mitral Stenosis: An Evidence-Based Study. Indonesian Journal Obstetric and Gynecology. 2020. 8(1):1-4.
Silitonga C, Taufiq N, Setianto BY. Successful Balloon Mitral Valvuloplasty in 21-week Pregnant Patient with Severe Mitral Stenosis: A Case Report and Literature Review. Acta Cardiologia Indonesiana. 2019. 5(1):80-89.